Strube Randall W, Chen Si-Yi
Department of Cancer Biology, Wake Forest University Graduate School of Arts and Sciences, Winston-Salem, NC 27157, USA.
Methods. 2004 Oct;34(2):179-83. doi: 10.1016/j.ymeth.2004.04.003.
The ability of intracellular antibodies (intrabodies) to block the function of a target protein can be dependent on the stability of the single-chain antibody (sFv) when expressed in the intracellular environment. Low-affinity sFvs capable of reaching high steady-state levels can be more effective modulators of target proteins than high-affinity, unstable sFvs. In an effort to enhance the intracellular stability of sFvs when expressed as intrabodies, we have generated novel sFv-Fc fusion intrabodies. Fusion of the native sFv sequence with the entire heavy chain constant region fragment of IgG results in decreased turnover of the intrabody and enhanced steady-state accumulation of sFv-Fc protein, while maintaining the ability to target intrabody expression to sub-cellular compartments. Here, we describe the rationale and design for this strategy using two anti-cyclin E sFvs constructed for use as intrabodies.
细胞内抗体(intrabodies)阻断靶蛋白功能的能力可能取决于单链抗体(sFv)在细胞内环境中表达时的稳定性。能够达到高稳态水平的低亲和力sFv可能比高亲和力、不稳定的sFv更有效地调节靶蛋白。为了提高sFv作为细胞内抗体表达时的细胞内稳定性,我们构建了新型的sFv-Fc融合细胞内抗体。将天然sFv序列与IgG的整个重链恒定区片段融合,可降低细胞内抗体的周转率,增强sFv-Fc蛋白的稳态积累,同时保持将细胞内抗体表达靶向亚细胞区室的能力。在此,我们描述了使用构建用作细胞内抗体的两种抗细胞周期蛋白E sFv的该策略的原理和设计。